Marijuana Moment reports Arizona lawmakers have approved a bill in committee to promote research into the medical potential of psilocybin mushrooms for a variety of conditions, which could...
CAMH will study PEX010, Filament’s botanical psilocybin drug candidate, in a Health Canada-approved clinical trial for mild cognitive impairment VANCOUVER, BC, Feb. 14, 2023 /CNW/ – Filament Health Corp. (OTCQB:...
It looks like a pill, and it tastes just like one…but this isn’t your typical over-the-counter medication. Leading the charge in natural drug development, Vancouver-basedFilament Healthis...
The Case for Microdosing: Why Legalization Matters In a recent episode of the Third Wave Podcast, Vicente LLP founding partner Josh Kappel joined Ali Schaper, CEO and co-founder of...
Delta 9 Cannabis Inc (TSX:DN) said it has completed its first shipment of bulk dried cannabis flower to a customer in Australia, marking the company’s first export...
The Therapeutic Goods Administration (TGA) has announced that Psilocybin and MDMA will be able to be prescribed by specially qualified psychiatrists for the treatment of particular...
I suppose that why they’ve named their local Grid Iron team the Vikings .. Marijuana Moment reports on the long tortuous road to regulation in Minnesota....
The DEA disclosed in a letter this week that it considers products containing novel cannabinoids such as Delta-9 and Delta-8 THCO, also known as THC acetate ester, to...
As businesses in Canada scrambled to market their cannabis products when recreational cannabis use was legalized in 2018 (“Legalization“), some brands filed trademark applications for cannabis-related...
In a decision released on 3 February 2023, the Australian Therapeutic Goods Administration (TGA) have agreed to amend the Poisons Standard to include new Schedule 8...
